<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Immunology &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/category/news/science-news/immunology/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jul 2021 15:00:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Immunology &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>UMass Amherst grad student awarded fellowship for food allergy research</title>
		<link>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/</link>
					<comments>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:00:35 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Environmental Health]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Food/Food Science]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Microbiology]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/</guid>

					<description><![CDATA[USDA program focuses on developing next generation of food scientists Credit: UMass Amherst University of Massachusetts Amherst food science Ph.D. candidate Cassandra Suther has received a prestigious predoctoral fellowship of $180,000 from the U.S. Department of Agriculture&#8217;s National Institute of Food and Agriculture (USDA-NIFA) to study the effect of norovirus on the development and severity [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/umass-amherst-grad-student-awarded-fellowship-for-food-allergy-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174475</post-id>	</item>
		<item>
		<title>Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested</title>
		<link>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/</link>
					<comments>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jul 2021 18:58:03 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Mathematics/Statistics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/</guid>

					<description><![CDATA[Analysis suggests same epidemiological outcomes possible with rapid-antigen versus RT-PCR tests Credit: Philip Cherian, Sandeep Krishna and Gautam Menon, 2021, PLOS Computational Biology A computational analysis of COVID-19 tests suggests that, in order to minimize the number of infections in a population, the amount of testing matters more than the sensitivity of the tests that [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/less-sensitive-covid-19-tests-may-still-achieve-optimal-results-if-enough-people-tested/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174408</post-id>	</item>
		<item>
		<title>Public trust in CDC, FDA, and Fauci holds steady, survey shows</title>
		<link>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/</link>
					<comments>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 20 Jul 2021 17:59:28 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Mass Media]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Mental Health]]></category>
		<category><![CDATA[Perception/Awareness]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/</guid>

					<description><![CDATA[But heavy users of conservative media have less confidence and are more likely to believe in conspiracy theories Credit: Annenberg Public Policy Center of the University of Pennsylvania With more than two-thirds of American adults vaccinated with at least one dose of an authorized Covid-19 vaccine, the top U.S. health agencies retain the trust of [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/public-trust-in-cdc-fda-and-fauci-holds-steady-survey-shows/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174170</post-id>	</item>
		<item>
		<title>USC study shows male-female differences in immune cell function</title>
		<link>https://bioengineer.org/usc-study-shows-male-female-differences-in-immune-cell-function/</link>
					<comments>https://bioengineer.org/usc-study-shows-male-female-differences-in-immune-cell-function/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 20:00:50 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Aging]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Gerontology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Sex-Linked Conditions]]></category>
		<guid isPermaLink="false">https://bioengineer.org/usc-study-shows-male-female-differences-in-immune-cell-function/</guid>

					<description><![CDATA[Credit: Ryan Lu A new USC study of a common, yet poorly understood type of white blood cell reveals the immune cell&#8217;s response to pathogens differs greatly by sex and by age. In this mouse study, males proved much more susceptible to a condition called sepsis than females. However, the scientists also found that the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/usc-study-shows-male-female-differences-in-immune-cell-function/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174088</post-id>	</item>
		<item>
		<title>CHOP researchers establish novel approach for developing new antibiotics</title>
		<link>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/</link>
					<comments>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 14:58:39 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmaceutical Chemistry]]></category>
		<category><![CDATA[Pharmaceutical Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/</guid>

					<description><![CDATA[New study proposes structure-guided design to create prodrugs that act as a &#8220;Trojan Horse,&#8221; allowing antibiotics to reach resistant bacteria Credit: CHOP Philadelphia, July 19, 2021&#8211;Researchers at Children&#8217;s Hospital of Philadelphia (CHOP) have developed a novel method for producing new antibiotics to combat resistant bacteria. Through an approach that would target bacteria with an antibiotic [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/chop-researchers-establish-novel-approach-for-developing-new-antibiotics/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">174007</post-id>	</item>
		<item>
		<title>3D &#8220;assembloid&#8221; shows how SARS-CoV-2 infects brain cells</title>
		<link>https://bioengineer.org/3d-assembloid-shows-how-sars-cov-2-infects-brain-cells/</link>
					<comments>https://bioengineer.org/3d-assembloid-shows-how-sars-cov-2-infects-brain-cells/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 21:04:10 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Cell Biology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/3d-assembloid-shows-how-sars-cov-2-infects-brain-cells/</guid>

					<description><![CDATA[Credit: UC San Diego Health Sciences Researchers at University of California San Diego School of Medicine and Rady Children&#8217;s Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain. The findings are published in the July 9, [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/3d-assembloid-shows-how-sars-cov-2-infects-brain-cells/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173971</post-id>	</item>
		<item>
		<title>Study finds vaccine hesitancy lower in poorer countries</title>
		<link>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/</link>
					<comments>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 19:10:21 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medical/Scientific Ethics]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/</guid>

					<description><![CDATA[New study examines vaccine acceptance and hesitancy in 10 low- and middle-income countries in Asia, Africa, and South America Credit: Fadil Fauzi New research published in Nature Medicine reveals willingness to get a COVID-19 vaccine was considerably higher in developing countries (80% of respondents) than in the United States (65%) and Russia (30%). The study [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-finds-vaccine-hesitancy-lower-in-poorer-countries/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173969</post-id>	</item>
		<item>
		<title>Researchers surprised to find bacterial parasites behind rise of &#8216;super bugs&#8217;</title>
		<link>https://bioengineer.org/researchers-surprised-to-find-bacterial-parasites-behind-rise-of-super-bugs/</link>
					<comments>https://bioengineer.org/researchers-surprised-to-find-bacterial-parasites-behind-rise-of-super-bugs/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 19:03:10 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Bacteriology]]></category>
		<category><![CDATA[Biodiversity]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Evolution]]></category>
		<category><![CDATA[Genes]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Population Biology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/researchers-surprised-to-find-bacterial-parasites-behind-rise-of-super-bugs/</guid>

					<description><![CDATA[Credit: Vaughn Cooper PITTSBURGH, July 16, 2021 &#8211; For the first time ever, researchers from the University of Pittsburgh School of Medicine discovered that phages&#8211;tiny viruses that attack bacteria&#8211;are key to initiating rapid bacterial evolution leading to the emergence of treatment-resistant &#8220;superbugs.&#8221; The findings were published today in Science Advances. The researchers showed that, contrary [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/researchers-surprised-to-find-bacterial-parasites-behind-rise-of-super-bugs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173967</post-id>	</item>
		<item>
		<title>Study identifies monoclonal antibodies that may neutralize many norovirus variants</title>
		<link>https://bioengineer.org/study-identifies-monoclonal-antibodies-that-may-neutralize-many-norovirus-variants/</link>
					<comments>https://bioengineer.org/study-identifies-monoclonal-antibodies-that-may-neutralize-many-norovirus-variants/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 15:58:42 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-identifies-monoclonal-antibodies-that-may-neutralize-many-norovirus-variants/</guid>

					<description><![CDATA[Credit: Vanderbilt University Medical Center Researchers at Vanderbilt University Medical Center (VUMC) and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract. Each year in the United States circulating strains of the human norovirus are [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-identifies-monoclonal-antibodies-that-may-neutralize-many-norovirus-variants/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173927</post-id>	</item>
		<item>
		<title>Wildfire smoke exposure linked to increased risk of contracting COVID-19</title>
		<link>https://bioengineer.org/wildfire-smoke-exposure-linked-to-increased-risk-of-contracting-covid-19/</link>
					<comments>https://bioengineer.org/wildfire-smoke-exposure-linked-to-increased-risk-of-contracting-covid-19/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 16 Jul 2021 13:58:22 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Climate Change]]></category>
		<category><![CDATA[Climate Science]]></category>
		<category><![CDATA[Ecology/Environment]]></category>
		<category><![CDATA[Forestry]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pollution/Remediation]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Temperature-Dependent Phenomena]]></category>
		<guid isPermaLink="false">https://bioengineer.org/wildfire-smoke-exposure-linked-to-increased-risk-of-contracting-covid-19/</guid>

					<description><![CDATA[New study finds a 17.7 percent rise in COVID-19 cases after a prolonged 2020 wildfire smoke event in Reno, Nev. Credit: U.S. Department of Agriculture Reno, Nev. (July 15, 2021) &#8211; Wildfire smoke may greatly increase susceptibility to SARS-CoV-2, the virus that causes COVID-19, according to new research from the Center for Genomic Medicine at [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/wildfire-smoke-exposure-linked-to-increased-risk-of-contracting-covid-19/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173907</post-id>	</item>
		<item>
		<title>Short chain fatty acids: An &#8216;ace in the hole&#8217; against SARS-CoV-2 infection</title>
		<link>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/</link>
					<comments>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/#comments</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jul 2021 16:01:55 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/</guid>

					<description><![CDATA[Scientists find that short chain fatty acids can be used to reduce susceptibility to SARS-CoV-2 infection and mortality from COVID-19 Credit: Kanako Yoshida from University of Fukui Humans are no stranger to coronavirus (CoV) pandemics. Just like SARS-CoV-2 (the virus that causes COVID-19), another member of the coronavirus family&#8211;SARS-CoV&#8211;caused the severe acute respiratory syndrome (SARS) [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/short-chain-fatty-acids-an-ace-in-the-hole-against-sars-cov-2-infection/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173765</post-id>	</item>
		<item>
		<title>Allocating COVID vaccines based on health and socioeconomic factors could cut mortality</title>
		<link>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/</link>
					<comments>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 19:07:06 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Socioeconomics]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/</guid>

					<description><![CDATA[Study suggests spatial relationship between COVID-19 mortality and population-level health factors Credit: Kandula S and Shaman J, 2021, PLOS Medicine, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) An estimated 43 percent of the variability in U.S. COVID-19 mortality is linked with county-level socioeconomic indicators and health vulnerabilities, with the strongest association seen in the proportions of people living with [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/allocating-covid-vaccines-based-on-health-and-socioeconomic-factors-could-cut-mortality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173679</post-id>	</item>
		<item>
		<title>Allocating COVID-19 vaccines based on health and socioeconomics could reduce mortality</title>
		<link>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</link>
					<comments>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 19:00:02 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Pulmonary/Respiratory Medicine]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/</guid>

					<description><![CDATA[Study suggests spatial relationship between COVID-19 mortality and population-level health factors Credit: Kandula S and Shaman J, 2021, PLOS Medicine COVID-19 vaccination strategies in the United States are informed by individual characteristics such as age and occupation. A study published in the open access journal PLOS Medicine by Sasikiran Kandula and Jeffrey Shaman of Columbia [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/allocating-covid-19-vaccines-based-on-health-and-socioeconomics-could-reduce-mortality/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173677</post-id>	</item>
		<item>
		<title>One shot of the Sputnik V vaccine triggers strong antibody responses</title>
		<link>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/</link>
					<comments>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jul 2021 16:58:37 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Vaccines]]></category>
		<guid isPermaLink="false">https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/</guid>

					<description><![CDATA[Credit: Rossi and Ojeda et al./Cell Reports Medicine A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine. &#8220;Due to limited vaccine supply and uneven vaccine distribution in many regions of the world, health authorities urgently need data [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/one-shot-of-the-sputnik-v-vaccine-triggers-strong-antibody-responses/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173665</post-id>	</item>
		<item>
		<title>Brandon Jutras receives Emerging Leader Award to advance Lyme disease research</title>
		<link>https://bioengineer.org/brandon-jutras-receives-emerging-leader-award-to-advance-lyme-disease-research/</link>
					<comments>https://bioengineer.org/brandon-jutras-receives-emerging-leader-award-to-advance-lyme-disease-research/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jul 2021 14:59:39 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biochemistry]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Chemistry/Physics/Materials Sciences]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pain]]></category>
		<category><![CDATA[Public Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/brandon-jutras-receives-emerging-leader-award-to-advance-lyme-disease-research/</guid>

					<description><![CDATA[Credit: Virginia Tech. The Bay Area Lyme Foundation, the leading not-for-profit sponsor of Lyme disease research in the United States, recently announced its three recipients of the 2021 Emerging Leader Awards, including Brandon Jutras, an assistant professor of biochemistry in the Virginia Tech College of Agriculture and Life Sciences and an expert in Lyme disease [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/brandon-jutras-receives-emerging-leader-award-to-advance-lyme-disease-research/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173521</post-id>	</item>
		<item>
		<title>&#8216;Smart collar&#8217; could prevent tapeworms in dogs</title>
		<link>https://bioengineer.org/smart-collar-could-prevent-tapeworms-in-dogs/</link>
					<comments>https://bioengineer.org/smart-collar-could-prevent-tapeworms-in-dogs/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 19:07:20 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Disease in the Developing World]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Parasitology]]></category>
		<category><![CDATA[Pets/Ethology]]></category>
		<category><![CDATA[Physiology]]></category>
		<category><![CDATA[Public Health]]></category>
		<category><![CDATA[Zoology/Veterinary Science]]></category>
		<guid isPermaLink="false">https://bioengineer.org/smart-collar-could-prevent-tapeworms-in-dogs/</guid>

					<description><![CDATA[Credit: Yang S-J et al., 2021, PLOS Neglected Tropical Diseases, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) Dogs infected with echinococcosis play a major role in spreading tapeworms across human populations around the world. Now, researchers have developed a &#8220;smart collar&#8221; which gradually delivers a steady dose of a deworming drug to dogs. The collar successfully reduces the animals&#8217; [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/smart-collar-could-prevent-tapeworms-in-dogs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173397</post-id>	</item>
		<item>
		<title>Regular monitoring may be only way to prevent large COVID-19 outbreaks in schools</title>
		<link>https://bioengineer.org/regular-monitoring-may-be-only-way-to-prevent-large-covid-19-outbreaks-in-schools/</link>
					<comments>https://bioengineer.org/regular-monitoring-may-be-only-way-to-prevent-large-covid-19-outbreaks-in-schools/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 19:00:14 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Algorithms/Models]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Diagnostics]]></category>
		<category><![CDATA[Epidemiology]]></category>
		<category><![CDATA[Health Care Systems/Services]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/regular-monitoring-may-be-only-way-to-prevent-large-covid-19-outbreaks-in-schools/</guid>

					<description><![CDATA[New simulations suggest that waiting until a student tests positive is too late for prevention Credit: Paul Tupper (CC BY 4.0, https://creativecommons.org/licenses/by/4.0/) A new study examines factors that underlie COVID-19 outbreaks in schools and suggests that large outbreaks can only be prevented with regular monitoring of everyone in the school setting. Paul Tupper and Caroline [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/regular-monitoring-may-be-only-way-to-prevent-large-covid-19-outbreaks-in-schools/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173393</post-id>	</item>
		<item>
		<title>Why we need to talk openly about vaccine side effects</title>
		<link>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/</link>
					<comments>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 16:10:40 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Behavior]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Language/Linguistics/Speech]]></category>
		<category><![CDATA[Mass Media]]></category>
		<category><![CDATA[Medical/Scientific Ethics]]></category>
		<category><![CDATA[Political Science]]></category>
		<category><![CDATA[Social/Behavioral Science]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/</guid>

					<description><![CDATA[We need to talk openly about vaccine side effects if we are to defeat the coronavirus pandemic Credit: Aarhus University Concerns have been raised about the AstraZeneca and Johnson &#038; Johnson vaccines regarding very rare but potentially fatal side effects related to low blood platelet counts and blood clots. Recently, reports also emerged that the [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/why-we-need-to-talk-openly-about-vaccine-side-effects/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173361</post-id>	</item>
		<item>
		<title>Arab participation in global genomic study could lead to new therapies for COVID patients</title>
		<link>https://bioengineer.org/arab-participation-in-global-genomic-study-could-lead-to-new-therapies-for-covid-patients/</link>
					<comments>https://bioengineer.org/arab-participation-in-global-genomic-study-could-lead-to-new-therapies-for-covid-patients/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jul 2021 16:03:37 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biology]]></category>
		<category><![CDATA[Genetics]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/arab-participation-in-global-genomic-study-could-lead-to-new-therapies-for-covid-patients/</guid>

					<description><![CDATA[Researchers from Qatar Foundation Research, Development, and Innovation&#8217;s Qatar Genome Programme contribute toward global initiative that can lead to therapeutic targets in addition to the protection conferred by the vaccines Credit: Qatar Foundation Doha, Qatar, July 8, 2021: In March 2020, thousands of scientists around the world united to answer a pressing and complex question: [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/arab-participation-in-global-genomic-study-could-lead-to-new-therapies-for-covid-patients/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173359</post-id>	</item>
		<item>
		<title>Study reveals how our immune system reacts to COVID-19 variants</title>
		<link>https://bioengineer.org/study-reveals-how-our-immune-system-reacts-to-covid-19-variants/</link>
					<comments>https://bioengineer.org/study-reveals-how-our-immune-system-reacts-to-covid-19-variants/#respond</comments>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jul 2021 13:57:44 +0000</pubDate>
				<category><![CDATA[Immunology]]></category>
		<category><![CDATA[Immunology/Allergies/Asthma]]></category>
		<category><![CDATA[Infectious/Emerging Diseases]]></category>
		<category><![CDATA[Medicine/Health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/study-reveals-how-our-immune-system-reacts-to-covid-19-variants/</guid>

					<description><![CDATA[Credit: Australian Red Cross Lifeblood Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not as effective against contemporary variants of the virus. The research is one of the world&#8217;s most comprehensive studies of the immune response [&#8230;]]]></description>
		
					<wfw:commentRss>https://bioengineer.org/study-reveals-how-our-immune-system-reacts-to-covid-19-variants/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">173206</post-id>	</item>
	</channel>
</rss>
